NUFLOR 4% PREMIX DIN 02339579
Status: Cancelled Pre Market
Holder: INTERVET CANADA CORP
Health Canada record
| Active ingredient(s) | FLORFENICOL 40 G |
|---|
| Dosage form | Drug Premix |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | |
|---|
| Current status date | 22-Jun-2022 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Intervet Canada Corp. — licence 100147, currently licensed, last inspection rating C (2023-07-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FLORFENICOL
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02231742 | AQUAFLOR | INTERVET CANADA CORP | Drug Premix | FLORFENICOL 500 G | Marketed |
| 02472953 | CLARO | ELANCO CANADA LIMITED | Solution | FLORFENICOL 16.6 MG; TERBINAFINE (TERBINAFINE HYDROCHLORIDE) 14.8 MG; MOMETASONE FUROATE 2.2 MG | Marketed |
| 02497166 | FENISOLVE | NORBROOK LABORATORIES LTD. | Solution | FLORFENICOL 300 MG | Marketed |
| 02458527 | FLORKEM | CEVA ANIMAL HEALTH INC | Solution | FLORFENICOL 300 MG | Marketed |
| 02216558 | NUFLOR | INTERVET CANADA CORP | Solution | FLORFENICOL 300 MG | Marketed |
| 02526654 | PAQ FLOR | PHIBRO ANIMAL HEALTH CORPORATION | Drug Premix | FLORFENICOL 500 G | Marketed |
| 02330997 | RESFLOR | INTERVET CANADA CORP | Solution | FLORFENICOL 300 MG; FLUNIXIN (FLUNIXIN MEGLUMINE) 16.5 MG | Marketed |
| 02555670 | SIMPLERA | VETOQUINOL N A INC | Solution | FLORFENICOL 16.6 MG; TERBINAFINE HYDROCHLORIDE 16.6 MG; MOMETASONE FUROATE 2.2 MG | Marketed |
| 02501015 | ZELERIS | CEVA ANIMAL HEALTH INC | Solution | FLORFENICOL 400 MG; MELOXICAM 5 MG | Marketed |
| 02287803 | NUFLOR | INTERVET CANADA CORP | Solution | FLORFENICOL 23 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 10872 | 2009-12-18 | New Drug Submission (NDS) | |
Request a quote for NUFLOR 4% PREMIX
How to read a Canadian DIN record